Video Experimental Relacionado
Updated: May 6, 2026

05:19
Practical Methodology of Cognitive Tasks Within a Navigational Assessment
Published on: June 1, 2015
15.6K
Un marco para implementar la navegación de atención de la demencia de alta calidad: recomendaciones de la Mesa
Morgan Daven1, David M Bass2, Nicole Deaner1
1Alzheimer's Association, Chicago, Illinois, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 30, 2026
Resumen
La Mesa Redonda de Navegación de Atención de la Demencia (DCN) estableció estándares para la capacitación y definió roles para mejorar la calidad de la atención de la demencia. Las recomendaciones se centran en enfoques centrados en la persona y la familia y en la creación de un modelo financiero sostenible para los servicios de DCN.
Conclusiones:
- Los roles definidos y la capacitación estandarizada son cruciales para la Navegación de Atención de la Demencia (DCN) de calidad.
- Un caso de negocio sostenible requiere demostrar el valor a los pagadores y alinearse con las métricas de atención médica.
- Los principios de atención centrada en la persona y la familia deben guiar toda la implementación de DCN.
Videos de Conceptos Relacionados
Documentation in Long-Term and Home Healthcare Setting
1.6K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.6K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Dementia
696
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
696
Alzheimer Disease l: Introduction
38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

